Yan Ding, Gang Li and Li-Juan Xiong contributed equally to this work.
The authors declare that they have no competing interests.
YD, GL and LX conducted the work. WY took part in statistical analysis. JL and FL participated in data collection. RW and KX performed the patient observation. SZ carried out the data checking. Lei Zhao designed the research. All authors read and approved the final manuscript.
The responses of immunological factors to different subtypes of Kawasaki disease (KD) remain poorly understood.
We recruited 388 patients with KD, 160 patients with infectious febrile disease and 85 normal children who served as control subjects. Both the levels and percentages of T lymphocyte subsets, natural killer cells (NK cells) and B cells were analyzed via flow cytometry. The levels of serum IgG, IgM, IgA and C3, C4 were assessed via velocity scatter turbidimetry.
The most significant differences noted between the patients with infectious febrile disease and the normal children were the elevated levels of B cells, C3 and the ratio of CD4/CD8, and the decreased levels of CD8+ T cells and NK cells, as well as the moderate increase in the absolute value of the CD3+ cells. The decreased T cell levels and the elevated B cell levels were helpful in distinguishing typical KD from atypical KD; the elevated T cell levels, the elevated NK cell and B cell levels and the decreased B cell levels were helpful in predicting the effectiveness of IVIG; low C3 and C4 levels were linked with prodromal infections.
Lymphocytes subsets and complement markers may be useful in differentiating among the different subtypes of KD and in helping clinicians understand the pathophysiology of KD.
Takahashi K, Oharaseki T, Yokouchi Y. Pathogenesis of Kawasaki disease. Clin ExpImmunol. 2011;164 Suppl 1:20–2.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747–71. CrossRefPubMed
Galeotti C, Bayry J, Kone-Paut I, Kaveri SV. Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmunity Rev. 2010;9:441–8. CrossRef
Bayers S, Shulman ST, Paller AS. Kawasaki disease: part II. Complications and treatment. J Am Acad Dermatol. 2013;69:513.e1–8. quiz 521–522. CrossRef
- Profiles of responses of immunological factors to different subtypes of Kawasaki disease
- BioMed Central
Neu im Fachgebiet Orthopädie und Unfallchirurgie
Mail Icon II